Bitcoin
$38,732.46
+734.14
Ethereum
$2,094.53
+7.8
Litecoin
$71.76
+1.79
DigitalCash
$30.66
+0.53
Monero
$171.93
+1.82
Nxt
$0.00
0
Ethereum Classic
$19.06
+0.21
Dogecoin
$0.08
0

VRTX Earnings: Highlights of Vertex Pharmaceuticals’ Q3 2023 results

0

Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The company also provided guidance for fiscal 2023.

September-quarter earnings, adjusted for special items, moved up to $4.08 per share from $4.01 per share in the same period of 2022. Unadjusted profit was $1.04 billion or $3.97 per share, vs. $930.5 million or $3.59 per share a year earlier.

The company said that third-quarter revenues increased to $2.48 billion from $2.33 billion in the year-ago period. For the whole of fiscal 2023, the management expects total product revenues to be in the range of $9.85 billion.

Prior Performance

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

WP2Social Auto Publish Powered By : XYZScripts.com